Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery.
Agrati
Chiara
C
National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy.
Marianecci
Carlotta
C
Sennato
Simona
S
Carafa
Maria
M
Bordoni
Veronica
V
Cimini
Eleonora
E
Tempestilli
Massimo
M
Pucillo
Leopoldo P
LP
Turchi
Federica
F
Martini
Federico
F
Borioni
Giorgio
G
Bordi
Federico
F
D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000378:metabolism; D004164:Diphosphonates / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000378:metabolism; D007962:Leukocytes / Q000378:metabolism; D008081:Liposomes; D008213:Lymphocyte Activation / Q000187:drug effects*; D008264:Macrophages / Q000378:metabolism; D050997:Nanomedicine; D011107:Polylysine / Q000737:chemistry / Q000378:metabolism; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism; D013601:T-Lymphocytes / Q000378:metabolism*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D008081:Liposomes; D016692:Receptors, Antigen, T-Cell, gamma-delta; D011107:Polylysine; D000077211:Zoledronic Acid